Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: United States Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20031
20042
20052
20072
20086
20093
20101
20131
20142
20151
20161
20171
20185
20195
20203
20212
20228
20235
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting17
Terminated9
Active, not recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11
Northwell Health5
Travere Therapeutics, Inc.5
University of Michigan5
Goldfinch Bio, Inc.3
Vertex Pharmaceuticals Incorporated3
Amgen2
Columbia University2
Kaneka Medical America LLC2
Akebia Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental64
Nephrosis, Lipoid21
Proteinuria19
Nephrotic Syndrome17
Kidney Diseases13
Glomerulonephritis, IGA7
Glomerulonephritis, Membranous7
Diabetic Nephropathies6
Renal Insufficiency, Chronic5
Nephritis, Hereditary4

Trials

Showing 51 to 64 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.